← Eichor
Study identifier: NCT05849129 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Adjunctive Intravenous Ascorbic Acid for Advanced Non-Small Cell Lung Cancer

Condition: Lung Cancer  ·  Sponsor: The Canadian College of Naturopathic Medicine

PhasePhase 2
Planned participants90
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This is a two arm RCT evaluating the effect of intravenous vitamin C versus placebo in patients with incurable non-small cell lung cancer. Participants in both arms will be receiving platinum doublet chemotherapy with or without concurrent immunotherapy as standard care. We plan to enroll 90 patients over 5 years.

This description comes directly from the study's public registry record.

Talk to the study team

Dugald Seely, ND, MSc  ·  613-792-1222  ·  dseely@thechi.ca

Mark Legacy, BSc, CCRP  ·  613-792-1222  ·  mlegacy@thechi.ca

Always discuss trial participation with your own doctor first.

Locations (1)

The Ottawa HospitalOttawa, Ontario, CanadaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05849129